Multicorp Intl Stock Fundamentals

MCICDelisted Stock  USD 0  0.00  0.00%   
Multicorp Intl fundamentals help investors to digest information that contributes to Multicorp Intl's financial success or failures. It also enables traders to predict the movement of Multicorp Pink Sheet. The fundamental analysis module provides a way to measure Multicorp Intl's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Multicorp Intl pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Multicorp Intl Company Revenue Analysis

Multicorp Intl's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Multicorp Intl Revenue

    
  642.05 K  
Most of Multicorp Intl's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Multicorp Intl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Based on the latest financial disclosure, Multicorp Intl reported 642.05 K of revenue. This is 99.99% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 99.99% higher than that of the company.

Multicorp Intl Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Multicorp Intl's current stock value. Our valuation model uses many indicators to compare Multicorp Intl value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Multicorp Intl competition to find correlations between indicators driving Multicorp Intl's intrinsic value. More Info.
Multicorp Intl is rated below average in shares outstanding category among its peers. It is rated below average in revenue category among its peers . The ratio of Shares Outstanding to Revenue for Multicorp Intl is about  2,044 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Multicorp Intl by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Multicorp Intl's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Multicorp Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Multicorp Intl's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Multicorp Intl could also be used in its relative valuation, which is a method of valuing Multicorp Intl by comparing valuation metrics of similar companies.
Multicorp Intl is currently under evaluation in revenue category among its peers.

Multicorp Fundamentals

About Multicorp Intl Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Multicorp Intl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multicorp Intl using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multicorp Intl based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
MultiCorp International, Inc. does not have significant operations. The company was formerly known as XTend Medical Corporation and changed its name to MultiCorp International, Inc. in August 2012. Multicorp International operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Multicorp Pink Sheet

If you are still planning to invest in Multicorp Intl check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Multicorp Intl's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance